Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03246282Phase 1Suspended
Phase 1, open-label, single-arm trial. Primary endpoint: Visual Analog Scale Pain Score at 2 weeks. Started Feb 2017; status: suspended.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03246282.